Interactive Stepping Exercise on Memory
Primary Purpose
Amnestic Mild Cognitive Impairment, Interactive Stepping Exercise, Memory
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Interactive stepping exercise
Home exercise
Sponsored by
About this trial
This is an interventional treatment trial for Amnestic Mild Cognitive Impairment focused on measuring square stepping exercise, Amnestic mild cognitive impairment, Interactive stepping exercise, memory, cognitive function, executive function
Eligibility Criteria
Inclusion Criteria:
- Age≥50 years
- Complained of memory impairment
- Chinese Version Verbal Learning Test 10-minute delays ≤ 6 words
- MMSE score≥24 and CDR score=0.5
- Activities of daily living are intact
- DSM-IV criteria for the diagnosis of dementia is not met
Exclusion Criteria:
- Any significant neurologic disease other than suspected incipient Alzheimer's disease
- Psychotic features, contraindication of exercise... which could lead to difficulty complying with the protocol
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Interactive stepping exercise group
Home exercise group
Arm Description
Outcomes
Primary Outcome Measures
Chinese version verbal learning test
Selective reminding test
Wechsler Memory Scale-III
Logic memory test
Secondary Outcome Measures
Montreal Cognitive Assessment
Trail making test
Stroop test
Executive Interview
Full Information
NCT ID
NCT04103463
First Posted
September 20, 2019
Last Updated
September 23, 2019
Sponsor
National Yang Ming University
1. Study Identification
Unique Protocol Identification Number
NCT04103463
Brief Title
Interactive Stepping Exercise on Memory
Official Title
Effects of Interactive Stepping Exercise on Memory in Adults With Amnestic Mild Cognitive Impairment
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2019 (Anticipated)
Primary Completion Date
December 31, 2020 (Anticipated)
Study Completion Date
July 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Yang Ming University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
This is a randomized controlled trail. A total of 28 individuals with aMCI will be randomly assigned to either the ISE group or control group. The ISE intervention conducts three times a week for 16 weeks. Outcomes are measured at baseline and after intervention. The primary outcomes are the Chinese version verbal learning test (CVVLT), selective reminding test (SRT), and logic memory test (Wechsler Memory Scale). The secondary outcomes are Montreal Cognitive Assessment (MoCA) for cognitive function, and trail making test Part A & B (TMT-A & B), Stroop test, and 25-item Executive Interview (C-EXIT 25) for executive function.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Amnestic Mild Cognitive Impairment, Interactive Stepping Exercise, Memory, Cognitive Function, Executive Function
Keywords
square stepping exercise, Amnestic mild cognitive impairment, Interactive stepping exercise, memory, cognitive function, executive function
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Interactive stepping exercise group
Arm Type
Experimental
Arm Title
Home exercise group
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Interactive stepping exercise
Intervention Description
An exercise intervention based on the principle of square stepping exercise
Intervention Type
Other
Intervention Name(s)
Home exercise
Intervention Description
Home exercise
Primary Outcome Measure Information:
Title
Chinese version verbal learning test
Time Frame
Change from baseline at 12 week
Title
Selective reminding test
Time Frame
Change from baseline at 12 week
Title
Wechsler Memory Scale-III
Time Frame
Change from baseline at 12 week
Title
Logic memory test
Time Frame
Change from baseline at 12 week
Secondary Outcome Measure Information:
Title
Montreal Cognitive Assessment
Time Frame
Change from baseline at 12 week
Title
Trail making test
Time Frame
Change from baseline at 12 week
Title
Stroop test
Time Frame
Change from baseline at 12 week
Title
Executive Interview
Time Frame
Change from baseline at 12 week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age≥50 years
Complained of memory impairment
Chinese Version Verbal Learning Test 10-minute delays ≤ 6 words
MMSE score≥24 and CDR score=0.5
Activities of daily living are intact
DSM-IV criteria for the diagnosis of dementia is not met
Exclusion Criteria:
Any significant neurologic disease other than suspected incipient Alzheimer's disease
Psychotic features, contraindication of exercise... which could lead to difficulty complying with the protocol
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yea-Ru Yang
Phone
+886228267279
Email
yryang@ym.edu.tw
12. IPD Sharing Statement
Learn more about this trial
Interactive Stepping Exercise on Memory
We'll reach out to this number within 24 hrs